Clinical Trial Update: A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing BL-M07D1 to physician's choice chemotherapy in HER2-expressing platinum-resistant recurrent epithelial ovarian cancer, fallopia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• BL-M07D1
• Physician's Choice of Chemotherapy

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: NOT_YET_RECRUITING